請用此 Handle URI 來引用此文件：
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/84403完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 陳長謙 | zh_TW |
| dc.contributor.advisor | Sunney I. Chan | en |
| dc.contributor.author | 朱冠宇 | zh_TW |
| dc.contributor.author | Brett Kuan-Yu Chu | en |
| dc.date.accessioned | 2023-03-19T22:10:31Z | - |
| dc.date.available | 2023-11-10 | - |
| dc.date.copyright | 2022-02-21 | - |
| dc.date.issued | 2022 | - |
| dc.date.submitted | 2002-01-01 | - |
| dc.identifier.citation | Aguzzi, A., & Heppner, F. L. (2000). Pathogenesis of prion diseases: a progress report. Cell Death Differ, 7(10), 889-902. doi:10.1038/sj.cdd.4400737
Aguzzi, A., Sigurdson, C., & Heikenwaelder, M. (2008). Molecular mechanisms of prion pathogenesis. Annu Rev Pathol, 3, 11-40. doi:10.1146/annurev.pathmechdis.3.121806.154326 Apostol, M. I., Wiltzius, J. J. W., Sawaya, M. R., Cascio, D., & Eisenberg, D. (2011). Atomic structures suggest determinants of transmission barriers in mammalian prion disease. Biochemistry, 50(13), 2456-2463. doi:10.1021/bi101803k Araman, C., Thompson, R. E., Wang, S. Y., Hackl, S., Payne, R. J., & Becker, C. F. W. (2017). Semisynthetic prion protein (PrP) variants carrying glycan mimics at position 181 and 197 do not form fibrils. Chem Sci, 8(9), 6626-6632. doi:10.1039/c7sc02719b Beringue, V., Mallinson, G., Kaisar, M., Tayebi, M., Sattar, Z., Jackson, G., Anstee, D., Collinge, J., & Hawke, S. (2003). Regional heterogeneity of cellular prion protein isoforms in the mouse brain. Brain, 126, 2065-2073. doi:10.1093/brain/awg205 Burke, C., Walsh, D., Steele, A., Agrimi, U., Di Bari, M. A., Watts, J. C., & Supattapone, S. (2019). Full restoration of specific infectivity and strain properties from pure mammalian prion protein. PLos Pathog, 15(3), e1007662. doi:10.1371/journal.ppat.1007662 Caughey, B. W., Dong, A., Bhat, K. S., Ernst, D., Hayes, S. F., & Caughey, W. S. (1991). Secondary structure analysis of the scrapie-associated protein PrP 27-30 in water by infrared spectroscopy. Biochemistry, 30(31), 7672-7680. doi:10.1021/bi00245a003 Chatterjee, B., Lee, C.-Y., Lin, C., Chen, E. H. L., Huang, C.-L., Yang, C.-C., & Chen, R. P. Y. (2013). Amyloid core formed of full-length lecombinant mouse prion protein involves sequence 127–143 but not sequence 107–126. PLoS One, 8(7), e67967. doi:10.1371/journal.pone.0067967 Chen, C., & Dong, X. P. (2016). Epidemiological characteristics of human prion diseases. Infect Dis Poverty, 5(1), 47-57. doi:10.1186/s40249-016-0143-8 Cheng, H. M., Huang, W. Y. C., Tsai, T. W. T., Mou, Y., Chao, J. C. H., & Chan, J. C. C. (2013). Depletion of water molecules near the end stage of steric zipper formation. J Chin Chem Soc, 60(7), 794-800. doi:10.1002/jccs.201300073 Cheng, H. M., Tsai, T. W. T., Huang, W. Y. C., Lee, H. K., Lian, H. Y., Chou, F. C., Mou, Y., & Chan, J. C. C. (2011). Steric zipper formed by hydrophobic peptide fragment of syrian hamster prion protein. Biochemistry, 50(32), 6815-6823. doi:10.1021/bi200712z Chuang, C. C., Liao, T. Y., Chen, E. H. L., & Chen, R. P. Y. (2013). How do amino acid substitutions affect the amyloidogenic properties and seeding efficiency of prion peptides. Amino Acids, 45(4), 785-796. doi:10.1007/s00726-013-1522-0 Cobb, N. J., Sönnichsen, F. D., Mchaourab, H., & Surewicz, W. K. (2007). Molecular architecture of human prion protein amyloid: A parallel, in-register β-structure. Proc Natl Acad Sci U S A, 104(48), 18946-18951. doi:10.1073/pnas.0706522104 Damberger, F. F., Christen, B., Perez, D. R., Hornemann, S., & Wuthrich, K. (2011). Cellular prion protein conformation and function. Proc Natl Acad Sci U S A, 108(42), 17308-17313. doi:10.1073/pnas.1106325108 DeMarco, M. L., & Daggett, V. (2004). From conversion to aggregation: protofibril formation of the prion protein. Proc Natl Acad Sci U S A, 101(8), 2293-2298. doi:10.1073/pnas.0307178101 Donne, D. G., Viles, J. H., Groth, D., Mehlhorn, I., James, T. L., Cohen, F. E., Prusiner, S. B., Wright, P. E., & Dyson, H. J. (1997). Structure of the recombinant full-length hamster prion protein PrP(29-231): The N terminus is highly flexible. Proc Natl Acad Sci U S A, 94(25), 13452-13457. doi:10.1073/pnas.94.25.13452 Dyson, H. J., & Wright, P. E. (2005). Intrinsically unstructured proteins and their functions. Nat Rev Mol Cell Biol, 6(3), 197-208. doi:10.1038/nrm1589 Eschmann, N. A., Georgieva, E. R., Ganguly, P., Borbat, P. P., Rappaport, M. D., Akdogan, Y., Freed, J. H., Shea, J.-E., & Han, S. (2017). Signature of an aggregation-prone conformation of tau. Sci Rep, 7(1), 44739. doi:10.1038/srep44739 Freire, S., de Araujo, M. H., Al-Soufi, W., & Novo, M. (2014). Photophysical study of Thioflavin T as fluorescence marker of amyloid fibrils. Dyes Pigm, 110, 97-105. doi: 10.1016/j.dyepig.2014.05.004 Gasset, M., Baldwin, M. A., Lloyd, D. H., Gabriel, J. M., Holtzman, D. M., Cohen, F., Fletterick, R., & Prusiner, S. B. (1992). Predicted alpha-helical regions of the prion protein when synthesized as peptides form amyloid. Proc Natl Acad Sci U S A, 89(22), 10940-10944. doi:10.1073/pnas.89.22.10940 Glynn, C., Sawaya, M. R., Ge, P., Gallagher-Jones, M., Short, C. W., Bowman, R., Apostol, M., Zhou, Z. H., Eisenberg, D. S., & Rodriguez, J. A. (2020). Cryo-EM structure of a human prion fibril with a hydrophobic, protease-resistant core. Nat Struct Mol Biol, 27(5), 417-423. doi:10.1038/s41594-020-0403-y Gossert, A. D., Bonjour, S., Lysek, D. A., Fiorito, F., & Wuthrich, K. (2005). Prion protein NMR structures of elk and of mouse/elk hybrids. Proc Natl Acad Sci U S A, 102(3), 646-650. doi:10.1073/pnas.0409008102 Govaerts, C., Wille, H., Prusiner, S. B., & Cohen, F. E. (2004). Evidence for assembly of prions with left-handed β-helices into trimers. Proc Natl Acad Sci U S A, 101(22), 8342-8347. doi:10.1073/pnas.0402254101 Haire, L. F., Whyte, S. M., Vasisht, N., Gill, A. C., Verma, C., Dodson, E. J., Dodson, G. G., & Bayley, P. M. (2004). The crystal structure of the globular domain of sheep prion protein. J Mol Biol, 336(5), 1175-1183. doi:10.1016/j.jmb.2003.12.059 Holscher, C., Delius, H., & Burkle, A. (1998). Overexpression of nonconvertible PrPc Delta 114-121 in scrapie-infected mouse neuroblastoma cells leads to trans-dominant inhibition of wild-type PrPSc accumulation. J Virol, 72(2), 1153-1159. Hornshaw, M. P., McDermott, J. R., & Candy, J. M. (1995). Copper binding to the N-terminal tandem repeat regions of mammalian and avian prion protein. Biochem Biophys Res Commun, 207(2), 621-629. doi: 10.1006/bbrc.1995.1233 Jones, E. M., & Surewicz, W. K. (2005). Fibril conformation as the basis of species- and strain-dependent seeding specificity of mammalian prion amyloids. Cell, 121(1), 63-72. doi: 10.1016/j.cell.2005.01.034 Khan, M. Q., Sweeting, B., Mulligan, V. K., Arslan, P. E., Cashman, N. R., Pai, E. F., & Chakrabartty, A. (2010). Prion disease susceptibility is affected by β-structure folding propensity and local side-chain interactions in PrP. Proc Natl Acad Sci U S A, 107(46), 19808-19813. doi:10.1073/pnas.1005267107 Kleschyov, A. L., Wenzel, P., & Munzel, T. (2007). Electron paramagnetic resonance (EPR) spin trapping of biological nitric oxide. J Chromatogr B Analyt Technol Biomed Life Sci, 851(1-2), 12-20. doi:10.1016/j.jchromb.2006.10.006 Knaus, K. J., Morillas, M., Swietnicki, W., Malone, M., Surewicz, W. K., & Yee, V. C. (2001). Crystal structure of the human prion protein reveals a mechanism for oligomerization. Nat Struct Biol, 8, 770-774. doi:10.1038/nsb0901-770 Knaus, K. J., Morillas, M., Swietnicki, W., Malone, M., Surewicz, W. K., & Yee, V. C. (2001). Crystal structure of the human prion protein reveals a mechanism for oligomerization. Nature Structural Biology, 8(9), 770-774. doi:10.1038/nsb0901-770 Krebs, M. R. H., Bromley, E. H. C., & Donald, A. M. (2005). The binding of thioflavin-T to amyloid fibrils: localisation and implications. J Struct Biol, 149(1), 30-37. doi: 10.1016/j.jsb.2004.08.002 Kumar, J., Sreeramulu, S., Schmidt, T. L., Richter, C., Vonck, J., Heckel, A., Glaubitz, C., & Schwalbe, H. (2010). Prion protein amyloid formation involves structural rearrangements in the C-terminal domain. Chembiochem, 11(9), 1208-1213. doi:10.1002/cbic.201000076 Kuwata, K., Matumoto, T., Cheng, H., Nagayama, K., James, T. L., & Roder, H. (2003). NMR-detected hydrogen exchange and molecular dynamics simulations provide structural insight into fibril formation of prion protein fragment 106-126. Proc Natl Acad Sci U S A, 100(25), 14790-14795. doi:10.1073/pnas.2433563100 Langedijk, J. P. M., Fuentes, G., Boshuizen, R., & Bonvin, A. (2006). Two-rung model of a left-handed beta-helix for prions explains species barrier and strain variation in transmissible spongiform encephalopathies. J Mol Biol, 360(4), 907-920. doi:10.1016/j.jmb.2006.05.042 Lee, L. Y. L., & Chen, R. P. Y. (2007). Quantifying the sequence-dependent species barrier between hamster and mouse prions. J Am Chem Soc, 129(6), 1644-1652. doi:10.1021/ja0667413 Lu, X., Wintrode, P. L., & Surewicz, W. K. (2007). β-Sheet core of human prion protein amyloid fibrils as determined by hydrogen/deuterium exchange. Proc Natl Acad Sci U S A, 104(5), 1510-1515. doi:10.1073/pnas.0608447104 Makarava, N., & Baskakov, I. V. (2008). Expression and purification of full-length recombinant PrP of high purity. In A. F. Hill (Ed.), Methods Mol Biol (pp. 131-143). Totowa, NJ: Humana Press. McHaourab, H. S., Lietzow, M. A., Hideg, K., & Hubbell, W. L. (1996). Motion of spin-labeled side chains in T4 lysozyme, correlation with protein structure and dynamics. Biochemistry, 35(24), 7692-7704. doi:10.1021/bi960482k Millhauser, G. L. (2007). Copper and the prion protein: Methods, structures, function, and disease. Annu Rev Phys Chem, 58, 299-320. doi:10.1146/annurev.physchem.58.032806.104657 Muramoto, T., Scott, M., Cohen, F. E., & Prusiner, S. B. (1996). Recombinant scrapie-like prion protein of 106 amino acids is soluble. Proc Natl Acad Sci U S A, 93(26), 15457-15462. doi:10.1073/pnas.93.26.15457 Oesch, B., Westaway, D., Walchli, M., McKinley, M. P., Kent, S. B. H., Aebersold, R., Barry, R. A., Tempst, P., Teplow, D. B., Hood, L. E., Prusiner, S. B., & Weissmann, C. (1985). A cellular gene encodes scrapie PrP 27-30 protein. Cell, 40(4), 735-746. doi:10.1016/0092-8674(85)90333-2 Pan, K. M., Baldwin, M., Nguyen, J., Gasset, M., Serban, A., Groth, D., Mehlhorn, I., Huang, Z. W., Fletterick, R. J., Cohen, F. E., & Prusiner, S. B. (1993). Conversion of alpha-helices into beta-sheet feature in the formation of the scrapie prion protein. Proc Natl Acad Sci U S A, 90(23), 10962-10966. doi:10.1073/pnas.90.23.10962 Piro, J. R., Harris, B. T., Nishina, K., Soto, C., Morales, R., Rees, J. R., & Supattapone, S. (2009). Prion protein glycosylation is not required for strain-specific neurotropism. J Virol, 83(11), 5321-5328. doi:10.1128/jvi.02502-08 Prusiner, S. B. (1982). Novel proteinaceous infectious particles cause scrapie. Science, 216(4542), 136-144. doi:10.1126/science.6801762 Prusiner, S. B. (1991). Molecular-biology of prion disease. Science, 252(5012), 1515-1522. doi:10.1126/science.1675487 Riek, R., Hornemann, S., Wider, G., Billeter, M., Glockshuber, R., & Wüthrich, K. (1996). NMR structure of the mouse prion protein domain PrP(121–231). Nature, 382(6587), 180-182. doi:10.1038/382180a0 Sang, J. C., Lee, C.-Y., Luh, F. Y., Huang, Y.-W., Chiang, Y.-W., & Chen, R. P. Y. (2012). Slow spontaneous α-to-β structural conversion in a non-denaturing neutral condition reveals the intrinsically disordered property of the disulfide-reduced recombinant mouse prion protein. Prion, 6(5), 489-497. doi:10.4161/pri.22217 Serag, A. A., Altenbach, C., Gingery, M., Hubbell, W. L., & Yeates, T. O. (2001). Identification of a subunit interface in transthyretin amyloid fibrils: Evidence for self-assembly from oligomeric building blocks. Biochemistry, 40(31), 9089-9096. doi:10.1021/bi010655s Shen, H. C.-H., Chen, Y.-H., Lin, Y.-S., Chu, B. K.-Y., Liang, C.-S., Yang, C.-C., & Chen, R. P.-Y. (2019). Segments in the amyloid core that distinguish hamster from mouse prion pibrils. Neurochem Res, 44(6), 1399-1409. doi:10.1007/s11064-018-02709-w Shindoh, R., Kim, C. L., Song, C. H., Hasebe, R., & Horiuchi, M. (2009). The Region Approximately between Amino Acids 81 and 137 of Proteinase K-Resistant PrPSc Is Critical for the Infectivity of the Chandler Prion Strain. J Virol, 83(8), 3852-3860. doi:10.1128/jvi.01740-08 Smirnovas, V., Baron, G. S., Offerdahl, D. K., Raymond, G. J., Caughey, B., & Surewicz, W. K. (2011). Structural organization of brain-derived mammalian prions as probed by hydrogen exchange. Nat Struct Mol Biol, 18(4), 504-506. doi:10.1038/nsmb.2035 Sneideris, T., Ziaunys, M., Chu, B. K., Chen, R. P., & Smirnovas, V. (2020). Self-replication of prion protein fragment 89-230 amyloid fibrils accelerated by prion protein fragment 107-143 aggregates. Int J Mol Sci, 21(19). doi:10.3390/ijms21197410 Sobrova, P., Ryvolova, M., Adam, V., & Kizek, R. (2012). Capillary electromigration based techniques in diagnostics of prion protein caused diseases. Electrophoresis, 33(24), 3644-3652. doi:10.1002/elps.201200208 Spagnolli, G., Rigoli, M., Orioli, S., Sevillano, A. M., Faccioli, P., Wille, H., Biasini, E., & Requena, J. R. (2019). Full atomistic model of prion structure and conversion. PLos Pathog, 15(7), e1007864. doi:10.1371/journal.ppat.1007864 Supattapone, S., Bouzamondo, E., Ball, H. L., Wille, H., Nguyen, H. O. B., Cohen, F. E., DeArmond, S. J., Prusiner, S. B., & Scott, M. (2001). A protease-resistant 61-residue prion peptide causes neurodegeneration in transgenic mice. Mol Cell Biol, 21(7), 2608-2616. doi:10.1128/mcb.21.7.2608-2616.2001 Török, M., Milton, S., Kayed, R., Wu, P., McIntire, T., Glabe, C. G., & Langen, R. (2002). Structural and dynamic features of alzheimer's Aβ peptide in amyloid fibrils studied by site-directed spin labeling. J Biol Chem, 277(43), 40810-40815. doi:10.1074/jbc.M205659200 Tagliavini, F., Prelli, F., Verga, L., Giaccone, G., Sarma, R., Gorevic, P., Ghetti, B., Passerini, F., Ghibaudi, E., Forloni, G., Salmona, M., Bugiani, O., & Frangione, B. (1993). Synthetic peptides homologous to prion protein residues 106-147 from amyloid-like fibrils in-vitro. Proc Natl Acad Sci U S A, 90(20), 9678-9682. doi:10.1073/pnas.90.20.9678 Theint, T., Nadaud, P. S., Aucoin, D., Helmus, J. J., Pondaven, S. P., Surewicz, K., Surewicz, W. K., & Jaroniec, C. P. (2017). Species-dependent structural polymorphism of Y145Stop prion protein amyloid revealed by solid-state NMR spectroscopy. Nat Commun, 8(1), 753. doi:10.1038/s41467-017-00794-z Theint, T., Nadaud, P. S., Surewicz, K., Surewicz, W. K., & Jaroniec, C. P. (2017). 13C and 15N chemical shift assignments of mammalian Y145Stop prion protein amyloid fibrils. Biomol NMR Assign, 11(1), 75-80. doi:10.1007/s12104-016-9723-6 Torres, J., Stevens, T. J., & Samso, M. (2003). Membrane proteins: the 'Wild West' of structural biology. Trends Biochem Sci, 28(3), 137-144. doi:10.1016/s0968-0004(03)00026-4 Tycko, R., Savtchenko, R., Ostapchenko, V. G., Makarava, N., & Baskakov, I. V. (2010). The alpha-helical C-terminal domain of full-length recombinant PrP converts to an In-Register Parallel beta-sheet Structure in PrP fibrils: evidence from solid state nuclear magnetic resonance. Biochemistry, 49(44), 9488-9497. doi:10.1021/bi1013134 Vanik, D. L., Surewicz, K. A., & Surewicz, W. K. (2004). Molecular basis of barriers for interspecies transmissibility of mammalian prions. Mol Cell, 14(1), 139-145. doi:10.1016/S1097-2765(04)00155-8 Vázquez-Fernández, E., Vos, M. R., Afanasyev, P., Cebey, L., Sevillano, A. M., Vidal, E., Rosa, I., Renault, L., Ramos, A., Peters, P. J., Fernández, J. J., van Heel, M., Young, H. S., Requena, J. R., & Wille, H. (2016). The structural architecture of an infectious mammalian prion using electron cryomicroscopy. PLos Pathog, 12(9), e1005835. doi:10.1371/journal.ppat.1005835 Wang, L.-Q., Zhao, K., Yuan, H.-Y., Wang, Q., Guan, Z., Tao, J., Li, X.-N., Sun, Y., Yi, C.-W., Chen, J., Li, D., Zhang, D., Yin, P., Liu, C., & Liang, Y. (2020). Cryo-EM structure of an amyloid fibril formed by full-length human prion protein. Nat Struct Mol Biol, 27(6), 598-602. doi:10.1038/s41594-020-0441-5 Wang, Y. M., & Hall, C. K. (2018). Seeding and cross-seeding fibrillation of N-terminal prion protein peptides PrP(120-144). Protein Sci, 27(7), 1304-1313. doi:10.1002/pro.3421 Wang, Y. M., Shao, Q., & Hall, C. K. (2016). N-terminal prion protein peptides (PrP(120-144)) form parallel in-register beta-sheets via multiple nucleation-dependent pathways. J Biol Chem, 291(42), 22093-22105. doi:10.1074/jbc.M116.744573 Weickert, S., Cattani, J., & Drescher, M. (2019). Intrinsically disordered proteins (IDPs) studied by EPR and in-cell EPR. In Electron Paramagnetic Resonance: Volume 26 (Vol. 26, pp. 1-37): The Royal Society of Chemistry. Wille, H., Bian, W., McDonald, M., Kendall, A., Colby, D. W., Bloch, L., Ollesch, J., Borovinskiy, A. L., Cohen, F. E., Prusiner, S. B., & Stubbs, G. (2009). Natural and synthetic prion structure from X-ray fiber diffraction. Proc Natl Acad Sci U S A, 106(40), 16990-16995. doi:10.1073/pnas.0909006106 Wopfner, F., Weidenhofer, G., Schneider, R., von Brunn, A., Gilch, S., Schwarz, T. F., Werner, T., & Schatzl, H. M. (1999). Analysis of 27 mammalian and 9 avian PrPs reveals high conservation of flexible regions of the prion protein. J Mol Biol, 289(5), 1163-1178. doi:10.1006/jmbi.1999.2831 Xiao, X. Z., Yuan, J., Haik, S., Cali, I., Zhan, Y. A., Moudjou, M., Li, B. Y., Laplanche, J. L., Laude, H., Langeveld, J., Gambetti, P., Kitamoto, T., Kong, Q. Z., Brandel, J. P., Cobb, B. A., Petersen, R. B., & Zou, W. Q. (2013). Glycoform-selective prion formation in sporadic and familial forms of prion disease. PLoS One, 8(3). doi:10.1371/journal.pone.0058786 Yang, C., Lo, W.-L., Kuo, Y.-H., Sang, J. C., Lee, C.-Y., Chiang, Y.-W., & Chen, R. P. Y. (2015). Revealing structural changes of prion protein during conversion from α-helical monomer to β-oligomers by means of ESR and nanochannel encapsulation. ACS Chem Biol, 10(2), 493-501. doi:10.1021/cb500765e | - |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/84403 | - |
| dc.description.abstract | 普利昂疾病是一種可傳播的致命神經退化性疾病，並且可以在人類和哺乳動物之間傳播。其病原體是一種錯誤折疊的、抗蛋白酶的、且富含 β-折疊的普利昂蛋白聚集體，簡稱為 PrPSc。 PrPSc 從其天然形式的普利昂蛋白（稱為 PrPC）經結構轉化而來，並且可以自我堆疊形成感染性澱粉樣纖維。由於普利昂疾病的關鍵是澱粉樣纖維的形成，因此研究和識別蛋白質的哪些片段發生了結構轉變並參與澱粉樣纖維核心生成可以提供有關普利昂疾病的重要資訊。已知在部分變性條件下普利昂蛋白也可以自發形成非感染性澱粉樣原纖維。在這項研究中，我們利用定點突變、定點自旋標記、引晶實驗和電子自旋共振光譜的方法來研究試管內製備的全長小鼠普利昂蛋白的纖維結構核心。結果得知普利昂澱粉樣纖維的形成與 α到 β 結構轉換有關，主要涉及的區域為序列160-224，而該片斷原為普利昂蛋白中的第二條折板、第二條螺旋和第三條螺旋。我們的方法未來可用於研究感染性普利昂纖維或其他澱粉樣纖維的結構。此外，我們利用不同片段的普利昂蛋白或胜肽所形成的澱粉樣纖維作為種晶來檢查普利昂蛋白中片段108-144在形成澱粉樣纖維時扮演的角色。其結果顯示自發形成的纖維或由全長普利昂（23-230）纖維或縮短的普利昂蛋白（90-230）纖維誘發所形成的纖維，其片段108-144都不在澱粉樣纖維核心中，然而利用普利昂胜肽（108-144）纖維當作晶種時，在129與138這兩個位置上其電子自旋共振光譜有顯著的不同，這表明形成的纖維結構受普利昂胜肽纖維影響。 | zh_TW |
| dc.description.abstract | Prion diseases are a group of transmissible fatal neurodegenerative disorders spreading between humans and other mammals. The pathogenic agent, prion, is a misfolded, protease-resistant, β-sheet-rich protein aggregate called scrapie prion (PrPSc). PrPSc is converted from its native form of the cellular prion protein, called PrPC, and PrPSc can self-associate to form the infectious amyloid. Since the key hallmark in prion disease is amyloid formation, studying and recognizing which segments taking structural transformation and involved in the amyloid core can provide molecular details about prion diseases. It has been known that non-infectious amyloid fibrils could also be formed by prion protein under partially denaturing conditions. In this study, a combination of site-directed mutagenesis, site-directed spin-labeling, seeding assay, and electron spin resonance spectroscopy was employed to recognize the fibril structure of the in vitro prepared full-length mouse prion protein. Our results show that the amyloid core is formed from segment 160224, which includes the original strand 2, helix 2, and helix 3 in the prion protein. Our method can be applied to study the structure of infectious prions or other amyloid fibrils in the future. In addition, different lengths of PrP fibrils were used as seeds to examine the role of segment 108-144 in the amyloidogenesis of full-length prion protein. Our data show that segment 108-144 is not in the amyloid core in the spontaneously formed full-length PrP fibrils or the fibrils seeded by full-length PrP fibrils or PrP (90-230) fibrils. However, the ESR spectra of the fibrils with a spin-labeled at 129 or 138 have peak broadening, suggesting that the resulting fibril structure was altered by the peptide seed. | en |
| dc.description.provenance | Made available in DSpace on 2023-03-19T22:10:31Z (GMT). No. of bitstreams: 1 U0001-2001202214494100.pdf: 13518776 bytes, checksum: d80ee42241095f0d0a8dab1e993024f9 (MD5) Previous issue date: 2022 | en |
| dc.description.tableofcontents | 中文摘要 i
Abstract...........................................................................ii Contents..........................................................................iii Figure Contents....................................................................vi Table Contents.....................................................................ix Chapter 1 Introduction..............................................................1 1.1 Introduction to prion and prion disease.........................................1 1.2 The models of PrPSc and previous studies of prion fibril structures.............5 1.3 Critical regions of PrP in species barrier.....................................10 1.4 Electron spin resonance spectroscopy (ESR).....................................19 Chapter 2 Materials and Methods....................................................28 2.1 Materials......................................................................28 2.1.1 Water........................................................................28 2.1.2 Chemical.....................................................................28 2.2 Methods.......................................................................30 2.2.1 Expression constructs and site-directed mutagenesis..........................30 2.2.2 Solid-phase peptide synthesis................................................35 2.2.3 Mouse prion protein expression, purification, and identification.............37 2.2.2.1 Protein expression of recombinant mouse PrP................................37 2.2.2.2 Cell lysis.................................................................37 2.2.2.3 Immobilized metal ion affinity chromatography (IMAC).......................37 2.2.2.4 Protein purification by dialysis...........................................38 2.2.2.5 Protein purification by HPLC...............................................38 2.2.2.6 Protein purity, identification and quantification..........................39 2.2.4 MTSSL spin labeling, purification, and identification of labelled protein....40 2.2.5 Spontaneous fibrillation from recombinant mPrP monomer and the seeded fibril formation..........................................................................41 2.2.6 ThT (thioflavin T) binding assay.............................................42 2.2.7 Transition electron microscopy observation of mPrP fibril morphology.........43 2.2.8 Preparation of mPrP seeds and seeding assay..................................43 2.2.9 Sample preparation for ESR spectroscopy measurement..........................44 2.2.10 ESR spectroscopy measurement................................................45 2.2.11 Data analysis...............................................................45 Chapter 3 Results (I): Sample Preparation..........................................46 3.1 Expression of wild-type mPrP (23-230) and its mutant library...................46 3.1.1 Small scale expression of mutated mPrP.......................................49 3.1.2 Large scale expression of WT and mutated mPrP................................50 3.2 First purification Step：Immobilized metal-ion affinity chromatography.........53 3.3 Second purification step：Dialysis for WT......................................55 3.4 Final purification step：High Performance Liquid Chromatography (HPLC).........56 3.5 Spin-labeling and purification.................................................58 3.6 Protein identification and storage.............................................60 Chapter 4 Results (II): Amyloidonegesis of mouse prion protein.....................62 4.1 Spontaneous fibril formation of mPrP mutants with single spin labelled in the region of 108-144..................................................................62 4.2 Spontaneous fibril formation of mPrP mutants with single spin labelled in the C-terminal...........................................................................66 4.3 Spontaneous fibril formation of mPrP mutants with double spin labelled in the C-terminal region....................................................................71 4.4 ThT-Fluorescence, ESR and TEM results on seeded fibrils of wild-type mPrP and its mutants containing a single nitroxide spin-label...................................74 4.5 ThT-Fluorescence, ESR and TEM results on seeded fibrils of the wild-type mPrP and its mutants with double spin-labels................................................92 Chapter 5 Results (III): Fibril structures of the mouse prion protein seeded by different fibril seeds.............................................................99 5.1 Fibril formation of A113R1 mPrP mutant protein................................103 5.2 Fibril formation of L125R1 mPrP mutant protein................................104 5.3 Fibril formation of M129R1 mPrP mutant protein................................106 5.4 Fibril formation of M134R1 mPrP mutant protein................................107 5.5 Fibril formation of M138R1 mPrP mutant protein................................108 Chapter 6: Conclusion.............................................................110 Appendix A........................................................................112 Appendix B........................................................................144 Appendix C........................................................................149 Appendix D........................................................................157 Reference.........................................................................158 | - |
| dc.language.iso | zh_TW | - |
| dc.subject | 澱粉樣纖維 | zh_TW |
| dc.subject | 普利昂蛋白 | zh_TW |
| dc.subject | 定點自旋標記 | zh_TW |
| dc.subject | 引晶 | zh_TW |
| dc.subject | 電子自旋共振光譜 | zh_TW |
| dc.subject | electron spin resonance spectroscopy | en |
| dc.subject | Prion protein | en |
| dc.subject | seeding | en |
| dc.subject | site-directed spin-labeling | en |
| dc.subject | amyloid fibril | en |
| dc.title | 以自旋標定和電子自旋共振光譜分析全長小鼠普立昂蛋白類澱粉纖維之結構 | zh_TW |
| dc.title | Exploring the structure of mouse prion fibrils by site-directed spin-labeling and ESR spectroscopy | en |
| dc.type | Thesis | - |
| dc.date.schoolyear | 110-1 | - |
| dc.description.degree | 博士 | - |
| dc.contributor.author-orcid | 0000-0003-0495-9035 | |
| dc.contributor.coadvisor | 陳佩燁 | zh_TW |
| dc.contributor.coadvisor | Rita P.-Y. Chen | en |
| dc.contributor.coadvisor-orcid | 陳佩燁(0000-0003-3987-033X) | |
| dc.contributor.oralexamcommittee | 陳振中;江昀緯;黃人則 | zh_TW |
| dc.contributor.oralexamcommittee | Jerry Chun-Chung Chan;Yun-Wei Chiang;Joseph Jen-Tse Huang | en |
| dc.contributor.oralexamcommittee-orcid | 陳振中(0000-0002-5108-4166),江昀緯(0000-0002-2101-8918),黃人則(0000-0003-4847-7126) | |
| dc.subject.keyword | 普利昂蛋白,澱粉樣纖維,定點自旋標記,引晶,電子自旋共振光譜, | zh_TW |
| dc.subject.keyword | Prion protein,amyloid fibril,site-directed spin-labeling,seeding,electron spin resonance spectroscopy, | en |
| dc.relation.page | 164 | - |
| dc.identifier.doi | 10.6342/NTU202200114 | - |
| dc.rights.note | 同意授權(限校園內公開) | - |
| dc.date.accepted | 2022-01-25 | - |
| dc.contributor.author-college | 理學院 | - |
| dc.contributor.author-dept | 化學系 | - |
| dc.date.embargo-lift | 2022-02-21 | - |
| 顯示於系所單位： | 化學系 | |
文件中的檔案：
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-110-1.pdf 授權僅限NTU校內IP使用（校園外請利用VPN校外連線服務） | 13.2 MB | Adobe PDF |
系統中的文件，除了特別指名其著作權條款之外，均受到著作權保護，並且保留所有的權利。